<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html xmlns:v="urn:schemas-microsoft-com:vml"
  xmlns:o="urn:schemas-microsoft-com:office:office"
  xmlns:w="urn:schemas-microsoft-com:office:word"
  xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
  xmlns:mv="http://macVmlSchemaUri"
  xmlns="http://www.w3.org/TR/REC-html40">
  <head>
    <meta name="Title" content="APE">
    <meta name="Keywords" content="">
    <meta http-equiv="Content-Type" content="text/html;
      charset=windows-1252">
    <meta name="ProgId" content="Word.Document">
    <meta name="Generator" content="Microsoft Word 14">
    <meta name="Originator" content="Microsoft Word 14">
    <link rel="File-List" href="4renal_archivos/filelist.xml">
    <title>4</title>
    <!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Santi Ibañez Caturla</o:Author>
  <o:LastAuthor>Santi Ibañez Caturla</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>3393</o:TotalTime>
  <o:LastPrinted>2013-06-23T14:54:00Z</o:LastPrinted>
  <o:Created>2014-01-31T16:11:00Z</o:Created>
  <o:LastSaved>2014-01-31T18:13:00Z</o:LastSaved>
  <o:Pages>8</o:Pages>
  <o:Words>5974</o:Words>
  <o:Characters>32862</o:Characters>
  <o:Lines>273</o:Lines>
  <o:Paragraphs>77</o:Paragraphs>
  <o:CharactersWithSpaces>38759</o:CharactersWithSpaces>
  <o:Version>14.0</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
    <link rel="themeData" href="4renal_archivos/themedata.xml">
    <!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves/>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>ES-TRAD</w:LidThemeOther>
  <w:LidThemeAsian>JA</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
   <w:UseFELayout/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="276">
  <w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 9"/>
  <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
    <style>
<!--
 /* Font Definitions */
@font-face
	{font-family:"Courier New";
	panose-1:2 7 3 9 2 2 5 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"MS Mincho";
	mso-font-charset:78;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
	{font-family:"MS Mincho";
	mso-font-charset:78;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073743103 0 0 415 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
h1
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"T\00EDtulo 1 Car";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;
	mso-font-kerning:0pt;
	font-weight:normal;}
h2
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"T\00EDtulo 2 Car";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:13.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;
	font-weight:normal;}
h3
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"T\00EDtulo 3 Car";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:12.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#243F60;
	mso-themecolor:accent1;
	mso-themeshade:127;
	font-weight:normal;}
h4
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"T\00EDtulo 4 Car";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:12.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;
	font-weight:normal;
	font-style:italic;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Encabezado Car";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 212.6pt right 425.2pt;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Pie de p\00E1gina Car";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 212.6pt right 425.2pt;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList3, li.MsoList3, div.MsoList3
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:42.45pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList3CxSpFirst, li.MsoList3CxSpFirst, div.MsoList3CxSpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:42.45pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList3CxSpMiddle, li.MsoList3CxSpMiddle, div.MsoList3CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:42.45pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList3CxSpLast, li.MsoList3CxSpLast, div.MsoList3CxSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:42.45pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList4, li.MsoList4, div.MsoList4
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:56.6pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList4CxSpFirst, li.MsoList4CxSpFirst, div.MsoList4CxSpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:56.6pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList4CxSpMiddle, li.MsoList4CxSpMiddle, div.MsoList4CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:56.6pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoList4CxSpLast, li.MsoList4CxSpLast, div.MsoList4CxSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:56.6pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Texto de cuerpo Car";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
a:link, span.MsoHyperlink
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:purple;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
span.Ttulo1Car
	{mso-style-name:"T\00EDtulo 1 Car";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"T\00EDtulo 1";
	mso-ansi-font-size:16.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;}
span.Ttulo2Car
	{mso-style-name:"T\00EDtulo 2 Car";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"T\00EDtulo 2";
	mso-ansi-font-size:13.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;}
span.Ttulo3Car
	{mso-style-name:"T\00EDtulo 3 Car";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"T\00EDtulo 3";
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#243F60;
	mso-themecolor:accent1;
	mso-themeshade:127;}
span.Ttulo4Car
	{mso-style-name:"T\00EDtulo 4 Car";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"T\00EDtulo 4";
	font-family:Calibri;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"MS Gothic";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;
	font-style:italic;}
span.EncabezadoCar
	{mso-style-name:"Encabezado Car";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Encabezado;}
span.PiedepginaCar
	{mso-style-name:"Pie de p\00E1gina Car";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Pie de p\00E1gina";}
span.TextodecuerpoCar
	{mso-style-name:"Texto de cuerpo Car";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Texto de cuerpo";}
span.apple-converted-space
	{mso-style-name:apple-converted-space;
	mso-style-unhide:no;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:10.0pt;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
@page WordSection1
	{size:595.0pt 842.0pt;
	margin:36.0pt 36.0pt 36.0pt 36.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:12.3pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
@list l0
	{mso-list-id:60717730;
	mso-list-type:hybrid;
	mso-list-template-ids:-568027282 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1
	{mso-list-id:225461501;
	mso-list-type:hybrid;
	mso-list-template-ids:-1455929004 76576916 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2
	{mso-list-id:295457565;
	mso-list-type:hybrid;
	mso-list-template-ids:1791246346 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3
	{mso-list-id:399014901;
	mso-list-type:hybrid;
	mso-list-template-ids:-1739000108 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l3:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l3:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l3:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l3:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l4
	{mso-list-id:412974225;
	mso-list-type:hybrid;
	mso-list-template-ids:-2105479504 201981967 201981977 201981979 201981967 201981977 201981979 201981967 201981977 201981979;}
@list l4:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l4:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l4:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l4:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l4:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l4:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l4:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l4:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l4:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l5
	{mso-list-id:432284402;
	mso-list-type:hybrid;
	mso-list-template-ids:-1588142692 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l5:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l5:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l5:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l5:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l5:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l5:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l5:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l5:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l6
	{mso-list-id:443502795;
	mso-list-type:hybrid;
	mso-list-template-ids:-2105479504 201981967 201981977 201981979 201981967 201981977 201981979 201981967 201981977 201981979;}
@list l6:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l6:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l6:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l7
	{mso-list-id:543372317;
	mso-list-type:hybrid;
	mso-list-template-ids:453688770 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l7:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l7:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l7:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l7:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l7:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l7:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l7:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l7:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l7:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l8
	{mso-list-id:685137569;
	mso-list-type:hybrid;
	mso-list-template-ids:656732784 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l8:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l8:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l8:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l8:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l8:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l8:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l8:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l8:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l8:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l9
	{mso-list-id:794371369;
	mso-list-type:hybrid;
	mso-list-template-ids:-1993316312 76576916 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l9:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l9:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l9:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l9:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l9:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l9:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l9:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l9:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l9:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l10
	{mso-list-id:982927477;
	mso-list-type:hybrid;
	mso-list-template-ids:-958787624 -1386321556 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l10:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Cambria;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
@list l10:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l10:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l10:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l10:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l10:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l10:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l10:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l10:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l11
	{mso-list-id:1138913733;
	mso-list-type:hybrid;
	mso-list-template-ids:-1539113226 201981967 201981977 201981979 201981967 201981977 201981979 201981967 201981977 201981979;}
@list l11:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l11:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l11:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l11:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l11:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l11:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l11:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l11:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l11:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l12
	{mso-list-id:1223099451;
	mso-list-type:hybrid;
	mso-list-template-ids:-2105479504 201981967 201981977 201981979 201981967 201981977 201981979 201981967 201981977 201981979;}
@list l12:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l12:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l12:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l12:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l13
	{mso-list-id:1232083748;
	mso-list-type:hybrid;
	mso-list-template-ids:-410453224 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l13:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l13:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l13:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l13:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l13:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l13:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l13:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l13:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l13:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l14
	{mso-list-id:1235166370;
	mso-list-type:hybrid;
	mso-list-template-ids:872592248 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l14:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l14:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l14:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l14:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l14:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l14:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l14:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l14:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l14:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l15
	{mso-list-id:1323777463;
	mso-list-type:hybrid;
	mso-list-template-ids:-2105479504 201981967 201981977 201981979 201981967 201981977 201981979 201981967 201981977 201981979;}
@list l15:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l15:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l15:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l15:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l15:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l15:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l15:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l15:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l15:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l16
	{mso-list-id:1443458337;
	mso-list-type:hybrid;
	mso-list-template-ids:-1353309956 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l16:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l16:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l16:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l16:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l16:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l16:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l16:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l16:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l16:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l17
	{mso-list-id:1524976604;
	mso-list-type:hybrid;
	mso-list-template-ids:-38795060 -1386321556 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l17:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Cambria;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
@list l17:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l17:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l17:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l17:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l17:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l17:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l17:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l17:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l18
	{mso-list-id:1566530837;
	mso-list-type:hybrid;
	mso-list-template-ids:-2105479504 201981967 201981977 201981979 201981967 201981977 201981979 201981967 201981977 201981979;}
@list l18:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l18:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l18:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l18:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l18:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l18:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l18:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l18:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l18:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l19
	{mso-list-id:1624310395;
	mso-list-type:hybrid;
	mso-list-template-ids:1992213382 -179950164 201981977 201981979 201981967 201981977 201981979 201981967 201981977 201981979;}
@list l19:level1
	{mso-level-number-format:alpha-upper;
	mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l19:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l19:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l19:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l19:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l19:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l19:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l19:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l19:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l20
	{mso-list-id:1664115952;
	mso-list-type:hybrid;
	mso-list-template-ids:-939887544 -1379368454 201981977 201981979 201981967 201981977 201981979 201981967 201981977 201981979;}
@list l20:level1
	{mso-level-number-format:alpha-upper;
	mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l20:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l20:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l20:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l20:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l20:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l20:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l20:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l20:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l21
	{mso-list-id:1699623712;
	mso-list-type:hybrid;
	mso-list-template-ids:-46511316 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l21:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l21:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l21:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l21:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l21:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l21:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l21:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l21:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l21:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l22
	{mso-list-id:1826777404;
	mso-list-type:hybrid;
	mso-list-template-ids:-615889202 201981953 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l22:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l22:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l22:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l22:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l22:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l22:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l22:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l22:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l22:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l23
	{mso-list-id:1865091763;
	mso-list-type:hybrid;
	mso-list-template-ids:1855773246 -1386321556 201981955 201981957 201981953 201981955 201981957 201981953 201981955 201981957;}
@list l23:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Cambria;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
@list l23:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l23:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l23:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l23:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l23:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l23:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l23:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l23:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style><!--[if gte mso 10]>
<style>
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Tabla normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;}
table.MsoTableGrid
	{mso-style-name:"Tabla con cuadr\00EDcula";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-priority:59;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-border-insideh:.5pt solid windowtext;
	mso-border-insidev:.5pt solid windowtext;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1027"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
  </head>
  <body style="tab-interval:35.4pt" vlink="purple" link="blue"
    lang="ES-TRAD">
    <div class="WordSection1">
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph;
        tab-stops:145.3pt center 261.5pt"><span
          style="mso-ansi-language:ES" lang="ES"><o:p>&nbsp;</o:p></span></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph;
        tab-stops:145.3pt center 261.5pt"><span
          style="mso-ansi-language:ES" lang="ES"><o:p>&nbsp;</o:p></span></p>
      <p class="MsoNormal" style="text-align:center;tab-stops:145.3pt
        center 261.5pt" align="center"><b
          style="mso-bidi-font-weight:normal"><u><span
              style="font-size:16.0pt;
              mso-bidi-font-size:12.0pt">TEMA 19<o:p></o:p></span></u></b></p>
      <p class="MsoListParagraph"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l11 level1 lfo2"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">1.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">CLASIFICACIÓN
            DE LAS
            MALFORMACIONES RENALES<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Suelen
        estar presentes en el nacimiento, ya que suelen deberse a
        defectos adquiridos
        en la vida intrauterina, y pueden ser:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l16 level1 lfo3"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Alteraciones en la
        cantidad de parénquima renal</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16
        level3 lfo3"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Por
exceso:
        riñón supernumerario, renomegalia</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16
        level3 lfo3"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Por
defecto:
        agenesia renal, hipoplasia renal</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l16 level1 lfo3"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Alteraciones en la forma
        o posición del riñón:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Riñón
        ectópico</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Riñón
en
        herradura</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l16 level1 lfo3"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Alteraciones en la
        diferenciación:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Displasia
        renal</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Enfermedad
poliquística
        renal</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Enfermedad
quística
        medular</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l16 level1 lfo3"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Otros:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Enfermedad
quística
        renal ADQUIRIDA</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Quiste
renal
        multilocular</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l16
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Quiste
renal
        simple</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l16
        level2 lfo3"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Megacaliosis</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l11 level1 lfo2"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">2.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">DISPLASIA
            RENAL<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Alteración
de
        la diferenciación y desarrollo renal. Se debe a que el blastema
        NO se
        diferencia, por lo que hay áreas con estructuras embrionarias
        (indiferenciadas).</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l9 level1 lfo4"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">-<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Asociado frecuentemente a
        malformaciones de
        uréter y vías urinarias.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l9 level1 lfo4"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">-<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Dx: hay que encontrar
        estructuras embrionarias
        (como túbulos primitivos con mesénquima embrionario
        indiferenciado alrededor) o
        islotes de tejido cartilaginoso.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l9 level1 lfo4"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">-<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Puede ser de dos tipos:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l9
        level2 lfo4"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Displasia
focal
        SEGMENTARIA: el riñón parece normal pero tiene depresiones que
        parecen
        cicatrices.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l9
        level2 lfo4"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Displasia
renal
        MULTIQUÍSTICA: es como un racimo de uvas, formado por 8-10
        quistes muy
        grandes, con escaso parénquima entre ellos. Puede afectar a 1 o
        los 2 riñones.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l9
        level3 lfo4"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Bilateral:
incompatible
        con la vida.</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l9
        level3 lfo4"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Unilateral:
asociado
        a infecciones de repetición y HTA.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l11 level1 lfo2"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">3.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">ENFERMEDAD
            RENAL
            POLIQUÍSTICA<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Hay
        dos tipos según la edad:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l1 level1 lfo5"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">-<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal">DEL ADULTO</i>:
        es congénita y se hereda autosómica dominante. También se da en
        niños.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l1
        level2 lfo5"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Se
asocia
        a otras anomalías congénitas (tráquea, bronquios, intestino,
        aneurismas) y, en más de un 40%, hay también quistes (sobre
        todo hepáticos).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l1
        level2 lfo5"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Clínica:
los
        quistes existen al nacer, y son silentes hasta 30-40 años que
        crecen por
        acumulo de orina, provocando atrofia del parénquima e IR.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l1
        level2 lfo5"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Macro:
suele
        ser BILATERAL, con riñones muy GRANDES y abollados por
        muchísimos quistes
        redondos de <span
          style="mso-ascii-font-family:Cambria;mso-hansi-font-family:
          Cambria">&#8800;</span>tamaño, con orina (clara, turbia o
        hemorragia). Muy
        unidos, sin parénquima entre sí.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l1
        level2 lfo5"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Micro:
quistes
        debidos a dilatación de TÚBULOS o del ESPACIO DE BOWMAN en los
        glomérulos.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l1 level1 lfo5"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">-<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal">INFANTIL</i>:
        es congénita y autosómica recesiva, también BILATERAL.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l1
        level2 lfo5"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Se
asocia
        a malformaciones HEPÁTICAS (fibrosis y quistes)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l1
        level2 lfo5"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Macro:
riñones
        grandes pero LISOS, con muchos quistes alargados al corte que
        van hacia
        la medula (riñón en esponja).</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l1
        level2 lfo5"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Micro:
quistes
        debidos a dilataciones cilíndricas de TODOS LOS TÚBULOS
        COLECTORES.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal" style="text-align:center;tab-stops:145.3pt
        center 261.5pt" align="center"><b
          style="mso-bidi-font-weight:normal"><u><span
              style="font-size:16.0pt;
              mso-bidi-font-size:12.0pt">TEMA 20<o:p></o:p></span></u></b></p>
      <p class="MsoListParagraph"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l12 level1 lfo6"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">1.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">MECANISMO
            PATOGÉNICO DE LA
            LESIÓN GLOMERULAR<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Hay
        dos tipos:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l19 level1 lfo7"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><i
            style="mso-bidi-font-style:normal"><span
style="mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
                style="mso-list:Ignore">A)<span style="font:7.0pt
                  &quot;Times New Roman&quot;">&nbsp;&nbsp;
                </span></span></span></i></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><i
            style="mso-bidi-font-style:normal">MECANISMO INMUNITARIO<o:p></o:p></i></b></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l10 level1 lfo8"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Mediado por
          ANTICUERPOS: <o:p></o:p></u></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level2 lfo8"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->NEFRITIS
DE
        INMUNOCOMPLEJOS CIRCULANTES: </p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level3 lfo8"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Ac
se
        unen a Ag de la sangre, formándose inmunocomplejos que se
        depositan en el
        glomérulo. Si el deposito se repite y no se elimina, provoca un
        Fenómeno de
        Arthus glomerular:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level4 lfo8"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Estos IC activan el
        complemento y provocan una GN
        aguda (como la GN postestreptocócica), con PMN y proliferación
        de células
        (mesangiales y endoteliales)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level4 lfo8"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Con IF se ven depósitos
        granulares de Ig y
        complemento.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level2 lfo8"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->NEFRITIS
CONTRA
        ANTÍGENOS GOMERULARES:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level3 lfo8"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Ac
dirigidos
        directamente (in situ) contra Ag en el glomérulo. Pueden ser:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level4 lfo8"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Ag propios del glomérulo:
        NEFRITIS DE HEYMANN</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:180.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level5 lfo8"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Se
forman
        Ac contra el Ag Heymann (es una proteína, la Megalina, del borde
        en
        cepillo de células del TCP, parecido a uno que está en la célula
        epitelial
        glomerular de manera discontinua).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:180.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level5 lfo8"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Esto
provoca
        reacción cruzada con complejos Ac-Ag in situ, que activan el
        complemento y se depositan en la cara subepitelial de la
        membrana basal (se ven
        con IF).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level4 lfo8"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Ag previamente
        depositados en el glomérulo:
        NEFRITIS POR Ac ANTI MB. </p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:180.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level5 lfo8"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Se
forman
        Ac (IgG frías) contra péptidos de la MB (asociados a colágeno
        tipo IV),
        a veces también de otras MB (pulmón).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:180.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level5 lfo8"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Con
IF
        se ven depósitos de forma lineal en toda la MB glomerular.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-top:0cm;margin-right:0cm;
        margin-bottom:6.0pt;margin-left:71.7pt;mso-add-space:auto;text-align:justify;
text-justify:inter-ideograph;text-indent:-17.85pt;mso-list:l10
        level2 lfo8"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier
          New&quot;;mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Tras esta lesión
        inmunitaria se produce
        activación del complemento, agregación plaquetaria y se atraen
        PMN provocando
        un fenómeno de Arthus glomerular.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l10 level1 lfo8"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Mediado por CÉLULAS:</u>
        linfocitos T
        citotóxicos provocan lisis celular directa en células
        (mesangiales, epiteliales
        o endoteliales).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-top:0cm;margin-right:0cm;
        margin-bottom:6.0pt;margin-left:35.7pt;mso-add-space:auto;text-align:justify;
text-justify:inter-ideograph;text-indent:-17.85pt;mso-list:l10
        level1 lfo8"><!--[if !supportLists]--><span
          style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Mediado por
          COMPLEMENTO:</u> activación de la
        vía alternativa del complemento.</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l19 level1 lfo7"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><i
            style="mso-bidi-font-style:normal"><span
style="mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
                style="mso-list:Ignore">B)<span style="font:7.0pt
                  &quot;Times New Roman&quot;">&nbsp;&nbsp;
                </span></span></span></i></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><i
            style="mso-bidi-font-style:normal">MECANISMO NO INMUNITARIO<o:p></o:p></i></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Implicados
en
        el empeoramiento de las glomerulonefritis (por lo que son
        importantes en el
        pronóstico). Son:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l10 level1 lfo8"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Lesión por ABLACIÓN
          RENAL: <o:p></o:p></u></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level2 lfo8"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Tras
la
        extirpación de masa renal, hay un proceso compensador de los
        glomérulos restantes:
        hipertrofia, aumento de flujo y de la presión intracapilar.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level2 lfo8"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Esto
provoca
        aumento de la filtración y acumulo de proteínas y fibrina en la
        matriz
        mesangial (por activación de las células mesangiales).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level2 lfo8"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Este
crecimiento
        de la matriz mesangial (llamado glomeruloesclerosis focal y
        segmentaria) estrecha las luces capilares, que desaparecen. Se
        van destruyendo
        nefronas, dando un círculo vicioso que llega a IRC irreversible.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l10 level1 lfo8"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Lesión DIRECTA de
          células epiteliales: <o:p></o:p></u></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level2 lfo8"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Debido
a
        distintos procesos (en que intervienen citocinas, Ac, tóxicos)
        las células
        de epitelio pierden sus pedicelos y las uniones con la lámina
        rara externa de
        la MB, provocando su DESPRENDIMIENTO de esta.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level2 lfo8"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->NUNCA
hay
        depósitos de inmunocomplejos.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l10 level1 lfo8"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Lesión
          TÚBULO-INTERSTICIAL:<o:p></o:p></u></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level2 lfo8"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Cualquier
enfermedad
        glomerular se acompaña de otras lesiones, en las que interviene
        la
        proteinuria (que activa a las células del epitelio tubular),
        provocando:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level3 lfo8"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Producción
de
        citocinas tubulares: LESION TUBULAR.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level3 lfo8"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Reclutamiento
de
        células inflamatorias: INFILTRADO LINFOPLASMOCITARIO.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l10
        level3 lfo8"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->FIBROSIS
        INTERSTICIAL.</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-indent:-18.0pt;mso-list:l12 level1 lfo6"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">2.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">CLASIFICACIÓN
            DE LAS
            GLOMERULONEFRITIS<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Según
        su presentación clínica, se dividen en:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Lesiones que cursan con
        síndrome nefrótico:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->GN
de
        cambios mínimos o nefrosis<span style="mso-spacerun:yes">&nbsp;
        </span>lipoidea</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Glomeruloesclerosis
segmentaria
        y focal</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->GN
        Membranosa</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->GN
membrano-proliferativas
        tipos I y II.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Recuerda: Síndrome
        nefrótico = proteinuria &gt;
        3,5g/día, hipoalbuminemia, hiperlipidemia con lipiduria y
        edemas. Son por
        alteración de la filtración.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Lesiones asociadas a
        síndrome nefrítico:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->GN
aguda
        post-infecciosa o proliferativa (endocapilar)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->GN
con
        medias lunas (extracapilar)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Nefropatía
por
        IgA (Enfermedad de Berger)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Recuerda: Síndrome
        nefrítico = hematuria
        macroscópica, proteinuria leve y HTA (con posible oliguria). Son
        por depósito
        de inmunocomplejos.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Lesiones asociadas a
        enfermedades sistémicas:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Diabetes:
nefropatía
        diabética.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Amiloidosis
        renal</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->LES</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Endocarditis
        bacteriana</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Paraproteinemias</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Nefritis hereditarias</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Síndrome
de
        Alport</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Enfermedad
de
        la membrana basal fina (hematuria benigna familiar)</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->GN crónica</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-indent:-18.0pt;mso-list:l12 level1 lfo6"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">3.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">ENFERMEDAD
            DE CAMBIOS
            MÍNIMOS O NEFROSIS LIPOIDEA<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Los
        cambios del glomérulo no se ven al MO, por lo que el diagnostico
        se hace con
        ME:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Etiología</u>:
        desconocida (se piensa
        disfunción de inmunidad de Linfocitos T).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Patogenia</u>: se
        pierden los polianiones del
        glomérulo, provocando un aumento de la filtración de albumina y
        una alteración
        de las células epiteliales (con pérdida de pedicelos).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Clínica</u>: síndrome
        nefrótico en NIÑOS (2-6
        años) tras una enfermedad respiratoria.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->SIN
HTA
        NI HEMATURIA.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Morfología</u>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->MO:
no
        se ven alteraciones glomerulares.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Debido
a
        menor presión oncótica (por la filtración de albumina) hay
        aumento de la
        secreción de lipoproteínas en el hígado, provocando depósito de
        lípidos en las
        células del TCP (de ahí el nombre de nefrosis lipoidea).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->IF:
a
        veces débil reacción mesangial para IgM y C3, pero sin
        depósitos.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->ME:
perdida
        uniforme y difusa de pedicelos (con aplanamiento y
        vacuolización),
        sustituidos por una banda de vacuolización citoplasmática.</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Pronóstico y
          tratamiento</u>: muy bueno,
        responde al tratamiento con corticoides.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-indent:-18.0pt;mso-list:l12 level1 lfo6"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">4.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">GLOMERULOESCLEROSIS
            FOCAL Y
            SEGMENTARIA<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Hay
        esclerosis de algunos glomérulos, con sólo una porción de
        penacho afectada.</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Etiología</u>:
        idiopática (10-15%),
        superpuesta a otra lesión glomerular primaria (nefropatía IgA) o
        secundaria (a
        heroína, SIDA, analgésicos).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Patogenia</u>: se
        piensa que es una fase
        evolucionada de la GN de cambios mínimos, con mayor lesión de
        las células
        epiteliales (parece que la lesión por ablación puede ser
        importante).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Clínica</u>: síndrome
        nefrótico con proteinuria
        no selectiva, hematuria ocasional, disminución de la filtración
        glomerular e
        hipertensión.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Morfología</u>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->MO:
      </p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Primero
hay
        colapso parcial de la luz capilar por aumento de la matriz
        mesangial (por
        depósito de material hialino, mezclado con gotas de lípidos y
        células
        xánticas). Hay SINEQUIAS entre el penacho y la capsula de
        Bowman.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Al
evolucionar,
        la esclerosis afecta a todo el glomérulo, asociada a atrofia
        tubular y fibrosis intersticial.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->IF:
hay
        depósitos focales de IgM y C3 en las zonas hialinizadas.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->ME:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Vemos
una
        membrana basal plegada y engrosada.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Las
áreas
        normales al MO tienen perdida difusa de pedicelos y descamación
        de las
        células epiteliales.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Las
áreas
        hialinizadas tienen un material amorfo electrodenso y gránulos
        lipídicos.</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Pronostico y
          tratamiento</u>: mal pronóstico
        (20% evolución rápida a IR, sobre todo en SIDA; 50% IR terminal
        en 10 años). No
        responden bien a corticoides.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <table class="MsoTableGrid"
        style="border-collapse:collapse;border:none;mso-border-alt:solid
        windowtext .5pt; mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt
        0cm 5.4pt" cellspacing="0" cellpadding="0" border="1">
        <tbody>
          <tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes">
            <td style="width:253.5pt;border:solid windowtext 1.0pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="254" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center"><b style="mso-bidi-font-weight:normal">GN
                  DE CAMBIOS MÍNIMOS<o:p></o:p></b></p>
            </td>
            <td style="width:276.5pt;border:solid windowtext 1.0pt;
              border-left:none;mso-border-left-alt:solid windowtext
              .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm
              5.4pt 0cm 5.4pt" width="277" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center"><b style="mso-bidi-font-weight:normal">GLOMERULOESCLEROSIS
                  FOCAL Y SEGMENTARIA<o:p></o:p></b></p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:1">
            <td style="width:253.5pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="254" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Solo

                se ve al ME (no alteraciones MO)</p>
            </td>
            <td style="width:276.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="277" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Alteraciones

                MO y ME</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:2">
            <td style="width:253.5pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="254" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Proteinuria

                selectiva (albumina)</p>
            </td>
            <td style="width:276.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="277" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Proteinuria

                no selectiva</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:3">
            <td style="width:253.5pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="254" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">No

                HTA</p>
            </td>
            <td style="width:276.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="277" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Si

                HTA</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:4">
            <td style="width:253.5pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="254" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">No

                Hematuria</p>
            </td>
            <td style="width:276.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="277" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Si

                Hematuria (ocasional)</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:5">
            <td style="width:253.5pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="254" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Aumento

                de la filtración</p>
            </td>
            <td style="width:276.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="277" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Disminución

                de la filtración</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:6">
            <td style="width:253.5pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="254" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">MO:

                no (solo nefrosis lipoidea)</p>
            </td>
            <td style="width:276.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="277" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">MO:

                si (aumento matriz mesangial, sinequias)</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:7">
            <td style="width:253.5pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="254" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">IF:

                no hay depósitos IgM ni C3</p>
            </td>
            <td style="width:276.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="277" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">IF:

                si hay depósitos de IgM y C3 (zonas hialinizadas)</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:8">
            <td style="width:253.5pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="254" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">ME:

                perdida de pedicelos</p>
            </td>
            <td style="width:276.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="277" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">ME:

                descamación con pérdida de pedicelos, áreas hialinizadas
                y gránulos lipídicos, MB plegada gruesa</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:9;mso-yfti-lastrow:yes">
            <td style="width:253.5pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="254" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Buen

                pronóstico, respuesta corticoides</p>
            </td>
            <td style="width:276.5pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="277" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Mal

                pronóstico, mala respuesta a corticoides</p>
            </td>
          </tr>
        </tbody>
      </table>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-indent:-18.0pt;mso-list:l12 level1 lfo6"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">5.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">GN
            MEMBRANOSA<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Es
        una de las principales causas de síndrome nefrótico en el adulto
        (30-40%).</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Etiología</u>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->80%
desconocida,
        en individuos con susceptibilidad genética (Ag anti glomerulares
        modelo Heymann)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->20%
asociado
        a enfermedades conocidas (tumores malignos, LES, fármaco,
        infecciones)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Patogenia</u>:
        depósito de inmunocomplejos
        (principalmente in situ, 80%) en la región subepitelial de la
        membrana basal
        (glomerular), que provocan activación del complemento (complejo
        de ataque
        membrana MAC, C5b-C9).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Clínica</u>: comienza
        progresivamente un
        síndrome nefrótico o proteinuria no selectiva, hematuria ligera
        e HTA que no remite
        con corticoides. El 50% progresa a IR en 2-20 años.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Morfología</u>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->MO:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Inicial:
engrosamiento
        difuso y uniforme de la membrana basal, gotas hialinas en las
        células del TCP y espinas clavadas en la membrana basal
        (imagen en peine).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Avanzado:
estenosis
        de la luz capilar con esclerosis glomerular, atrofia tubular y
        fibrosis intersticial. El riñón se hace pequeño y de superficie
        granular.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->ME:
depósitos
        granulares entre la membrana basal y los podocitos, y
        prolongaciones
        espiculares que la membrana basal emite entre estos depósitos
        (los van
        cubriendo progresivamente). Este depósito finalmente hialiniza y
        oblitera todo
        el glomérulo.</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->IF:
vemos
        que los depósitos granulares contienen IgG y C3.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-indent:-18.0pt;mso-list:l12 level1 lfo6"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;
mso-bidi-font-size:12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:
minor-latin;mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin;
            mso-ansi-language:IT" lang="IT"><span
              style="mso-list:Ignore">6.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt;mso-ansi-language:
            IT" lang="IT">GN MEMBRANO-PROLIFERATIVA O MESANGIO-CAPILAR<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Lesión
        inflamatoria con proliferación celular (sobre todo mesangial);
        alteración de la
        membrana basal e infiltrado inflamatorio.</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Etiología</u>:
        desconocida (aunque hay casos
        secundarios a hepatitis, LES, endocarditis, infección)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Hay dos tipos (I y II),
        al MO tienen la misma
        morfología, pero tienen distinta patogenia, IF y ME.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>MO</u>:
        glomérulo más grande debido al aumento de células mesangiales y
        matriz
        mesangial. Hay células inflamatorias. Membrana basal engrosada y
        desdoblada
        (como railes de tren).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>TIPO I
            o CON DEPOSITOS SUBENDOTELIALES<o:p></o:p></u></i></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Patogenia:
formación
        de inmunocomplejos circulantes, por activación de la via clásica
        del
        complemento (C1-C4).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->ME:
las
        células mesangiales emiten prolongaciones (lengüetas) que
        disecan y
        desdoblan la membrana basal. Además hay depósitos
        subendoteliales y
        mesangiales.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->IF:
depósitos
        granulares de IgG y C1, C3 y C4.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>TIPO II
            o CON DEPOSITOS DENSOS<o:p></o:p></u></i></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Patogenia</u>:
        activa la vía alternativa del complemento, provocando
        proliferación mesangial,
        depósitos de C3 en el glomérulo con disminución de C3 en sangre.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>ME</u>:
        engrosamiento electrodenso en forma de láminas en la membrana
        basal, de
        composición desconocida.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>IF</u>:
        depósitos granulares de C3 a ambos lados de la membrana, sin
        depósitos de Ig.</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Representan el 5-10% en
        niños y adultos jóvenes.
        Evolución en un 50% a IRC en 10 años.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-indent:-18.0pt;mso-list:l12 level1 lfo6"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">7.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">GN
            POST-INFECCIOSA O
            PROLIFERATIVA (ENDOCAPILAR)<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Es
        una GN con cambios proliferativos y exudativos generalizados (y
        difusos por el
        glomérulo).</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Etiología</u>:
        infecciones de todo tipo (bacterias,
        virus, parásitos), pero la mayoría de veces debido a una cepa
        nefritógena del
        estreptococo beta hemolítico del grupo A.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Clínica</u>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->1º
infección
        amigdalar o cutánea. 2º cuadro de fiebre brusca con fiebre, mal
        estado general, nauseas, oliguria, hematuria.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Análisis
orina:
        importante, hay cilindros hemático.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Análisis
sangre
        elevación anti-estreptolisina O (ASO)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Patogenia</u>: hay
        complejos Ag-Ac en un 50%;
        además, durante los ataques disminuye el complemento en suero,
        por lo que
        sugiere un mecanismo mediado por inmunocomplejos.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Morfología</u>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->MO:
aumento
        del tamaño del glomérulo con proliferación difusa de células
        (mesangiales y endoteliales) e infiltrado de neutrófilos PMN.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->En
menos
        del 5% de los glomérulos se forman también medias lunas
        (proliferación de
        células epiteliales9.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->ME:
depósitos
        subepiteliales electrodensos en forma de jorobas, y a veces
        depósitos
        subendoteliales.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->IF:
depósitos
        granulares de IgG, IgM y C3 a lo largo de membrana basal y
        mesangio.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Pronostico</u>: muy
        bueno (remisión
        espontanea en 4-8 semanas).</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->En
el
        1% (sobre todo en los que forman medias lunas): GN rápidamente
        progresiva
        (con progresión rápida a IR).</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-indent:-18.0pt;mso-list:l12 level1 lfo6"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">8.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">GN
            PROLIFERATIVA FOCAL
            (FOCAL Y SEGMENTARIA)<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Es
        una GN en la que la proliferación células (de células
        mesangiales y
        endoteliales) afecta a solo algunos glomérulos (&lt;50%) y no a
        todo el penacho
        glomerular.</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Etiología</u>: puede
        ser idiopática, una
        manifestación precoz de algunas enfermedades (LES, síndrome de
        Goodpasture,
        endocarditis, síndrome de Wegener) o una manifestación
        morfológica de una
        nefropatía conocida (como la nefropatía por IgA).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Morfología</u>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->MO:
necrosis
        fibrinoide focal, proliferación celular difusa e infiltrado PMN
        variable.</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->IF/ME:
son
        diferentes según la etiología.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">***
        Supongo que cuando en las preguntas pone GN FOCAL Y SEGMENTARIA
        se refiere a la
        GLOMERULOESCLEROSIS (pregunta 4), porque esta me parece una
        chorrada, pero aun
        así la pongo.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-indent:-18.0pt;mso-list:l12 level1 lfo6"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">9.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">NEFROPATÍA
            POR IgA o
            ENFERMEDAD DE BERGER<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Es
        el tipo de GN más común en el adulto en algunas zonas.</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Patogenia</u>:
        relacionada con el aumento de síntesis
        de IgA en mucosas (por el contacto con agentes ambientales), se
        forman
        complejos circulantes que se depositan en el mesangio
        glomerular, activando el
        complemento y provocando lesión.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Clínica</u>: típicos
        de jóvenes y adultos,
        tras 1-2 días de enfermedad respiratoria, digestiva o urinaria.
        Suele comenzar
        con hematuria recidivante.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Morfología</u>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->MO:
puede
        comportarse como GN mesangio-proliferativa, GN proliferativa
        segmentaria
        y focal o GN rápidamente progresiva con formación de semilunas.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->SIEMPRE
se
        observa: proliferación de células mesangiales, necrosis de
        lobulillos
        glomerulares, depósito de fibrina. A veces hay formación de
        medias lunas (signo
        de mal pronóstico).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->ME:
depósitos
        electrodensos mesangiales.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->IF:
depósitos
        mesangiales de IgA y C3 (a veces se asocia también IgG, IgM, C1,
        C4).</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Pronostico</u>: al
        principio, evolución
        benigna, pero normalmente (50%), lentamente progresiva con
        evolución a IRC en
        20 años.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-indent:-18.0pt;mso-list:l12 level1 lfo6"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">10.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">NEFRITIS
            TÚBULO-INTERSTICIALES<o:p></o:p></span></b></p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l20 level1 lfo10"><!--[if !supportLists]--><span
style="mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
          mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
            style="mso-list:Ignore">A)<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>AGUDA O SECUNDARIA A
          FÁRMACOS<o:p></o:p></u></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Debida
        a reacciones de hipersensibilidad a fármacos (ampicilina,
        meticilina, AINEs).</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Clínica</u>: tras la
        toma de fármaco hay un
        periodo de latencia (2-40 días), y después, fiebre, eosinofilia,
        hematuria y
        proteinuria leve con aumento del nitrógeno ureico en sangre.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Morfología</u>: edema
        intersticial, con
        infiltrado de linfocitos y macrófagos (a veces también
        eosinófilos y
        neutrófilos). A veces también focos de necrosis y regeneración
        tubular.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Fármacos
como
        la meticilina provocan granulomas intersticiales con células
        gigantes
        multinucleadas.</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l20 level1 lfo10"><!--[if !supportLists]--><span
style="mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
          mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
            style="mso-list:Ignore">B)<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>CRÓNICA O POR ABUSO DE
          ANALGÉSICOS<o:p></o:p></u></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Es
        una enfermedad crónica renal secundaria al abuso y mezcla de
        analgésicos.</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Clínica</u>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->1º:
        <b style="mso-bidi-font-weight:normal">necrosis papilar</b> (con
        papilas en
        diversos estadios de necrosis, lo que lo diferencia de la
        diabetes).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->2º:
secundariamente,
        se produce <b style="mso-bidi-font-weight:normal">nefritis
          tubulointersticial</b> con fibrosis, inflamación crónica y
        atrofia tubular.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Macro</u>: zonas
        adelgazadas en la corteza
        (que son las papilas necrosadas) y ausencia de las puntas de las
        papilas.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Micro</u>: zonas de
        necrosis en las papilas
        (a veces con calcificaciones); las zonas corticales cercanas
        tienen fibrosis
        intersticial y atrofia tubular.</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Pronostico</u>: es
        importante el diagnostico
        precoz, ya que a veces hay regresión espontanea al retirar el
        fármaco. Si no se
        retira, el resultado siempre es IRC.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal" style="text-align:center;tab-stops:145.3pt
        center 261.5pt" align="center"><b
          style="mso-bidi-font-weight:normal"><u><span
              style="font-size:16.0pt;
              mso-bidi-font-size:12.0pt">TEMA 21<o:p></o:p></span></u></b></p>
      <p class="MsoListParagraph"
        style="text-indent:-18.0pt;mso-list:l15 level1 lfo1"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">1.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">CÁNCER
            RENAL<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">El
        carcinoma renal es el tumor más frecuente en el riñón. Afecta a
        personas de
        edad media y avanzada.</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Etiología</u>: deriva
        del epitelio tubular (a
        pesar de que su antiguo nombre, hipernefroma, indicaba que era
        de origen
        suprarrenal por su color amarillo).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Clínica</u>: triada
        hematuria (90%), dolor
        costovertebral y masa palpable (todo junto en 10%).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Si
alcanza
        gran tamaño: síndrome paraneoplásico (astenia, anorexia, pérdida
        de
        peso).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Pueden
ser
        secretores de hormonas (provocando policitemia, hipercalcemia,
        Cushing)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Pronostico</u>:
        metástasis frecuente y precoz
        (25% antes del diagnóstico) a pulmón, hueso, hígado y cerebro.
        Supervivencia
        75% sin metástasis y 15% con metástasis o invasión de vena
        renal.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Macro</u>: más
        frecuente en el polo superior
        del riñón.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Superficie
con
        áreas de colores alternadas: amarillentas (necrosis), rojas
        (hemorragia) y
        blanco-grisáceas (fibrosis)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Bordes
bien
        definidos, aunque a veces hay pequeños nidos satélites.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Debemos
explorar
        SIEMPRE la INVASION DE LA VENA RENAL (en forma de cordón
        hemático
        solido), ya que es signo de mal pronóstico.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Micro</u>:<b
          style="mso-bidi-font-weight:
          normal"> CLASIFICACIÓN HISTOLÓGICA</b>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>Carcinoma de células
            claras NO PAPILAR</u></i>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Es
la
        variedad más frecuente (hasta 80%). </p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Puede
ser
        tanto esporádico como familiar (típicamente asociado a Von
        Hippel-Lindau),
        pero se acompaña en ambos casos de delecciones en el cromosoma
        3.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->No
forma
        papilas: sus células se disponen en cordones o lóbulos (unos de
        células
        claras y grandes, y otros por células acidófilas).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>Carcinoma PAPILAR</u></i>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Representa
el
        10%, y no está asociado a alteraciones en el cromosoma 3 sino a
        otras
        alteraciones cromosómicas.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>Carcinoma renal
            CROMÓFOBO</u></i>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Es
el
        menos frecuente (5%), pero es el de mejor pronóstico, por lo que
        es importante
        un diagnostico precoz.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Formado
por
        células con una membrana nítida y citoplasma rosa poco teñido.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Otros
tipos:
        medular, quístico, colector</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->El factor pronostico más
        importante además del
        TNM y la invasión de la vena renal es el <i
          style="mso-bidi-font-style:normal">GRADO
          NUCLEAR<span style="mso-spacerun:yes">&nbsp; </span>DE
          FUHRMAN</i> (distingue los
        tumores en cuatro grados según el tamaño y morfología de núcleo
        y nucléolo).</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-indent:-18.0pt;mso-list:l15 level1 lfo1"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">2.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">TUMORES
            UROTELIALES O DEL
            SISTEMA COLECTOR, VEJIGA Y VÍAS<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Los
        tumores derivados de la pelvis renal, cálices, uréteres y vejiga
        se originan en
        el epitelio de revestimiento (de tipo transicional), denominado
        urotelio. Por
        tanto, se les llama tumores uroteliales.</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Etiología</u>: más
        frecuentes en fumadores,
        trabajadores de industrias (con anilinas y colorantes) y
        pacientes que han
        recibido tratamiento con ciclofosfamida o con nefropatía por
        analgésicos.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Clínica</u>: hematuria
        indolora con
        polaquiuria, disuria y a veces, retención urinaria y dilatación
        de vías. Son
        más frecuentes en varones mayores (50-80 años). </p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Clasificación</u>
        (tipos):</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>Papilomas</u></i>:
        únicos y pequeños.
        Pueden ser:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Exofíticos:
estructuras
        papilares con un eje conjuntivo vascular tapizado por urotelio
        de
        6-7 capas celulares sin atipias.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Invertidos:
masas
        sésiles que crecen hacia lamina propia sin infiltrar la
        muscular.</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>Neoplasia urotelial
            papilar de bajo
            potencial maligno</u></i>: son neoplasias aparentemente sin
        capacidad invasora
        o metastásica. Sus células tienen el menor citoplasma y no
        tienen nucléolos.
        Hay un urotelio normal tapizando las papilas y conservando la
        capa de células
        superficiales.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraphCxSpFirst"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>Carcinoma urotelial</u></i>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->De
bajo
        grado: similar a la NUPBPM pero más extensos, con más papilas
        tapizadas
        por un urotelio que tiene más de 7 capas. Células con mitosis y
        pleomorfismo
        nuclear (aunque leve), y no hay necrosis.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->De
alto
        grado: el urotelio tiene numerosas capas de células (con grupos
        compactos
        que infiltran lámina propia). Mas del 25% de las células con
        mitosis y atipias
        numerosas. </p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->En los de mayor grado,
        puede haber secreción
        hormonal (beta-HCG) y elementos heterogéneos de origen epitelial
        o mesenquimal.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Su morfología puede ser
        infiltrante, papilar o
        mixta.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Estadiaje</u>:
        se usa la <b style="mso-bidi-font-weight:normal">CLASIFICACIÓN
          DE
          JEWETT-MARSHALL</b>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Estadio
0:
        solo afecta al epitelio (membrana basal conservada).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Estadio
A:
        afecta a lámina propia.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Estadio
        B:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->B1: afecta a musculo
        detrusor superficial.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->B2: afecta a detrusor
        profundo.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Estadio
C:
        afecta al tejido paravesical y estructuras adyacentes (solo por
        continuidad).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Estadio
        D:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->D1: extensión linfática
        (afecta a ganglios
        regionales)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->D2: metástasis hematógena
        (afecta a órganos a
        distancia).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><u>Pronóstico</u>:
      </p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Estadios
0,
        A y B1 suelen tener buen pronostico</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Estadios
B2,
        C y D suelen ser carcinomas infiltrantes de alto grado y mal
        pronóstico.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal" style="text-align:center;tab-stops:145.3pt
        center 261.5pt" align="center"><b
          style="mso-bidi-font-weight:normal"><u><span
              style="font-size:16.0pt;
              mso-bidi-font-size:12.0pt">TEMA 22<o:p></o:p></span></u></b></p>
      <p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l6
        level1 lfo11"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">1.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">LINFOMA
            DE HODGKIN<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Constituye
un
        grupo de linfomas de distinto pronóstico con una característica
        común: la
        célula de Reed-Stenberg, una célula neoplásica especial.</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Clínica</u>: hay un
        aumento de tamaño de un
        ganglio o de una cadena ganglionar, pero sin dolor ni síntomas
        acompañantes
        (solo 10% con síntomas generales: fiebre, prurito, pérdida de
        peso).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Muchas
veces
        el paciente no nota el aumento de tamaño ganglionar (porque no
        alcanzan
        un tamaño suficiente o porque son cadenas internas, como la
        mediastínica).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Evolución</u>: se
        diseminan poco a poco a
        cadenas vecinas, y luego por la sangre (metástasis a distancia)
        a hígado, bazo
        o medula ósea. Distribución bimodal: primer pico a los 20 años y
        segundo en
        edad adulta (&gt;40 años).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Diagnostico</u>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->1º
detección
        de ganglio aumentado de tamaño: PAAF.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->2º
si
        se observan células R-S, extirpar el ganglio (confirmar dx y ver
        histología
        tumor).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->3º
estudio
        de extensión y estadiaje: biopsia (ósea y hepática), TAC y RMN.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Clasificación
          histológica</u>: </p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Linfoma
de
        Hodgkin <u>nodular de predominio linfocitico</u></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Linfoma
de
        Hodgkin <u>clásico</u>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]--><u>De
predominio
          linfocitico y/o histiocítico (PL):<o:p></o:p></u></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Típico de adultos
        jóvenes.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Pocas células neoplásicas
        y muchas reactivas (de
        tipo linfocitico o histiocítico), que pueden formar granulomas.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]--><u>Celularidad
mixta
          (CM):<o:p></o:p></u></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Se da a cualquier edad.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Equilibrio entre células
        neoplásicas y reactivas
        (hay linfocitos, células plasmáticas y eosinófilos). Puede verse
        necrosis
        ganglionar focal.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]--><u>Esclerosis
nodular
          (EN): <o:p></o:p></u></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Afecta sobre todo a
        mujeres jóvenes, sobre todo
        en mediastino.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Ganglio subdividido en
        nódulos por bandas de
        colágeno. 2 subtipos:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:180.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level5 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->EN
tipo
        I: celularidad mixta.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:180.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level5 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->EN
tipo
        II: similar a depleción linfocitaria.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]--><u>Depleción
linfocitaria
          (DL):<o:p></o:p></u></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Adultos de edad avanzada.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level4 lfo9"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Infiltrado con muchas
        células malignas y escasas
        células reactivas..</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Vemos
que
        un mayor número de células neoplasias y menor de células
        reactivas (las que
        expresan la respuesta inmunitaria del paciente) indica un peor
        pronóstico.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><b
          style="mso-bidi-font-weight:normal">Tipos de
          células de Reed-Stenberg:<o:p></o:p></b></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Su
origen
        es controvertido, aunque el 80% son positivas frente a
        marcadores tipo
        B.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Hay
cinco
        tipos, según su morfología:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>RS CLÁSICA</u></i>:
        gigante y binucleada,
        con núcleos en imagen especular en ojo de búho. Típicos de CM
        y EN tipo I.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>RS MONONUCLEADA</u></i>
        (célula de
        Hodgkin): en cualquier tipo, pero sobre todo CM.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>RS PLEOMÓRFICA</u></i>:
        multinucleada con
        núcleos irregulares en forma y tamaño. Típica de DL y EN tipo
        II.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>RS LACUNAR</u></i>:
        célula rodeada de un
        halo claro, una laguna (se retrae por la fijación en formol).
        Típica de EN
        tipo I.</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal"><u>RS en PALOMITA DE MAÍZ</u></i>:
        núcleo
        polilobulado. Típica de la variante nodular (de predominio
        linfocitico) y la
        clásica de predominio linfocitico/histiocítico.</p>
      <table class="MsoTableGrid"
        style="border-collapse:collapse;border:none;mso-border-alt:solid
        windowtext .5pt; mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt
        0cm 5.4pt" cellspacing="0" cellpadding="0" border="1">
        <tbody>
          <tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes">
            <td style="width:288.9pt;border:solid windowtext 1.0pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="289" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Linfoma

                nodular de predominio linfocitico</p>
            </td>
            <td style="width:241.1pt;border:solid windowtext 1.0pt;
              border-left:none;mso-border-left-alt:solid windowtext
              .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm
              5.4pt 0cm 5.4pt" width="241" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">RS

                en palomita de maíz</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:1">
            <td style="width:288.9pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="289" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Linfoma

                clásico de predominio linfocitico/histiocítico</p>
            </td>
            <td style="width:241.1pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="241" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">RS

                en palomita de maíz</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:2">
            <td style="width:288.9pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="289" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Linfoma

                con Celularidad Mixta</p>
            </td>
            <td style="width:241.1pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="241" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">RS

                clásica o RS mononucleada</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:3">
            <td style="width:288.9pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="289" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Linfoma

                con EN-I</p>
            </td>
            <td style="width:241.1pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="241" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">RS

                clásica o RS lacunar</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:4;mso-yfti-lastrow:yes">
            <td style="width:288.9pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="289" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Linfoma

                con EN-II y Depleción linfocitaria</p>
            </td>
            <td style="width:241.1pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="241" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">RS

                pleomórfica</p>
            </td>
          </tr>
        </tbody>
      </table>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Estadiaje</u>: </p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Se
usa
        la <b style="mso-bidi-font-weight:normal">CLASIFICACIÓN DE
          ANN-ARBOR:</b></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Estadio
I:
        afectación de UNA cadena ganglionar.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Estadio
II:
        afectación de DOS cadenas del MISMO lado del diafragma.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Estadio
III:
        afectación en cadenas a AMBOS lados del diafragma.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Estadio
IV:
        afectación visceral EXTRAGANGLIONAR (hígado, bazo, medula ósea):</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Se
subclasifica
        según la presencia de síntomas añadidos en:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->A:
ausencia
        de síntomas</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l17
        level3 lfo9"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->B:
presencia
        de síntomas.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l17 level1 lfo9"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Pronostico</u>:
        depende del tipo histológico
        y del estadio, con correlación entre ambos (linfomas de
        predominio linfocitico se
        diagnostican en estadio I, y linfomas con DL en estadio IV).</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l17
        level2 lfo9"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->La
supervivencia
        a 10 años en PL&gt;80%, EN-I=75%, CM=60%, EN-II=55%, DL=5%.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">*En
        el cuadro, recuerda que cualquier tipo de linfoma puede tener
        células RS
        mononucleadas.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">***RECORDATORIO
DE
        LINFOMAS NO HODGKIN: el 85% son de tipo B, y según sus células
        sean:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal">Células
          pequeñas</i> (linfocitos, centrocitos): crecimiento lento con
        curso clínico
        insidioso y largo, por tanto al momento del diagnóstico afectan
        a varias
        cadenas ganglionares y medula ósea.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l23
        level2 lfo12"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Resistentes
al
        tratamiento con quimioterapia.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l23
        level2 lfo12"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Ej.:
linfoma
        del manto.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><i
          style="mso-bidi-font-style:normal">Células
          grandes</i> (centroblastos, inmunoblastos): crecimiento
        rápido, por lo que al
        diagnóstico afectan a una sola cadena y no a medula ósea. Pero
        dejados
        libremente provocan la muerte a corto plazo. Suelen ser de
        localización
        primaria extraganglionar. </p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l23
        level2 lfo12"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Muy
sensibles
        a quimioterapia (incluso curan).</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l23
        level2 lfo12"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Ej.:
linfoma
        difuso de celulas grandes (con sus variantes).</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l6
        level1 lfo11"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">2.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">LINFOMA
            FOLICULAR<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Linfoma
        de tipo B que afecta a adultos de edad media, que presentan
        linfadenopatía
        generalizada.</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Morfología</u>: hay
        sustitución de la
        arquitectura en los ganglios, por nódulos compuestos por dos
        tipos de células:
        centrocitos (pequeñas) y centroblastos (grandes). Según el
        porcentaje de cada
        una hay varios subtipos:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l23
        level2 lfo12"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Grado
1:
        &lt;5 centroblastos por campo</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l23
        level2 lfo12"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Grado
2:
        5-15 centroblastos por campo</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l23
        level2 lfo12"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Grado
3:
        &gt;15 centroblastos por campo.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l23
        level3 lfo12"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Grado
3a:
        se acompaña también de centrocitos</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l23
        level3 lfo12"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Grado
3b:
        no hay centrocitos, solo centroblastos.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Etiología</u>: los
        pacientes muestran una
        translocación (14;18) que permite la sobreexpresión de la
        proteína bcl-2, que
        impide la apoptosis.</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Frecuente afectación
        extraganglionar (hígado,
        bazo y medula ósea). Además, en un 30% se transforma en un
        linfoma difuso de
        células grandes.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l6 level1 lfo11"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">3.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">TIPOS DE
            LINFOMA DE CÉLULAS
            GRANDES<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">**La
        verdad que no sé cuales son los linfomas de células grandes,
        llamadme
        ignorante</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Los
        linfomas de células grandes son un tipo de linfomas no Hodgkin
        que se
        caracterizan por:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Células grandes
        (centroblastos, inmunoblastos).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Crecimiento rápido, por
        lo que al diagnóstico
        afectan a una sola cadena y no a medula ósea. Pero dejados
        libremente provocan
        la muerte a corto plazo. </p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Suelen ser de
        localización primaria
        extraganglionar. </p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Muy sensibles a
        quimioterapia (incluso curan).</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Su
        máximo representante es el <b
          style="mso-bidi-font-weight:normal">LINFOMA
          DIFUSO DE CÉLULAS GRANDES</b>:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l13 level1 lfo13"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Es una masa de
        crecimiento rápido de un ganglio
        o extraganglionar (hueso, cerebro, tracto digestivo), pero no
        suele estar
        diseminado en el momento del diagnostico.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l13 level1 lfo13"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Caracterizado por
        infiltración por células
        linfoides grandes (CD19, CD20), con nucléolos grandes,
        frecuentes mitosis, que
        infiltran difusamente y destruyen la arquitectura del ganglio.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l13 level1 lfo13"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Sus variantes
        morfológicas son:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l13
        level2 lfo13"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Linfoma
centroblástico
        inmunoblastico rico en células T/Histiocitos</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l13
        level2 lfo13"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Linfoma
anaplásico
        plasmablástico ALK+</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l13 level1 lfo13"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Es una neoplasia muy
        agresiva, mortal con
        tratamiento, pero puede curar con quimioterapia.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l6
        level1 lfo11"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">4.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">LINFOMA
            DEL MANTO<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Linfoma
        de tipo B, donde en los ganglios afectados hay proliferación de
        células del
        manto folicular (rodeando el centro germinativo de los
        folículos).</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Morfología</u>: las
        células linfoides son
        pequeñas, de núcleos hendidos (y expresan CD20 y CD5).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Afecta a ganglios de
        forma diseminada, y
        normalmente también a medula ósea y bazo, incluso en un 30% hay
        linfocitosis en
        sangre periférica.</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->A veces constituye una
        poliposis linfomatoide
        multifocal en el intestino (delgado y grueso).</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l6
        level1 lfo11"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">5.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">LINFOMA
            DE LA ZONA MARGINAL<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Linfoma
        de tipo B (ya que las célula expresan CD20, y son CD5-).</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Etiología</u>:
        diversas translocaciones
        (11;18), (14;18), (1;14).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Localización</u>: se
        localiza en ganglios
        bazo y frecuentemente en tejido linfoide extraganglionar (en
        mucosas = Linfoma
        MALT, y órganos con inflamaciones autoinmunes = glándulas
        salivares y
        tiroides). </p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->En estomago aparece
        asociado a infección por
        Helicobacter Pylori; primero tiene un curso indolente que cura
        con AB, pero que
        se disemina en fases avanzadas.</p>
      <p class="MsoNormal"
        style="margin-left:18.0pt;text-align:justify;text-justify:
        inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="margin-left:18.0pt;text-align:justify;text-justify:
        inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l6
        level1 lfo11"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">6.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">MICOSIS
            FUNGOIDE (LINFOMA T
            CUTÁNEO EPIDERMOTRÓPICO)<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Linfoma
        de células T CD4+ (y por tanto CD3+),<span
          style="mso-spacerun:yes">&nbsp;
        </span>que afecta a adultos.</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Clínica</u>: afecta a
        la piel provocando
        manchas, placas y tumores, incluso eritrodermia ocasional.
        Cuando sale a sangre
        (fase leucémica), se le llama síndrome de Sézary.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Morfología</u>: las
        células linfocitarias
        tienen tropismo por la epidermis, y la infiltran, formando a
        veces agrupaciones
        llamadas microabcesos de Pautrier. Este evoluciona a infiltrado
        en banda y
        luego a tumor.</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Puede transformarse en un
        linfoma de alto grado.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l6 level1 lfo11"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">7.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">LESIONES
            ELEMENTALES DE LAS
            LINFADENITIS REACTIVAS<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Se
        llaman así las lesiones que caracterizan a las inflamaciones de
        los ganglios
        linfáticos (que pueden presentarse juntas o por separado). Son:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l7 level1 lfo14"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Linfadenitis aguda</u>:
        presencia de PMN en
        los ganglios linfáticos (a veces formando abscesos).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l7 level1 lfo14"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Hiperplasia folicular</u>:
        aumento del numero
        y tamaño de folículos linfoides, con aparición de centros
        germinativos. La
        vemos inflamaciones crónicas, en enfermedades reumáticas y en
        fases iniciales
        del SIDA.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l7 level1 lfo14"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Hiperplasia
          paracortical</u>: aumento de la
        población de linfocitos T en una franja ganglionar entre la
        corteza y la
        medula, que se ensancha por el gran numero de células. Típico de
        infecciones
        virales, como EBV (mononucleosis), y en las inflamaciones
        crónicas (donde hay
        hiperplasia folicular y paracortical).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l7 level1 lfo14"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Hiperplasia sinusal</u>:
        dilatación de los
        senos, que se llenan de muchos macrófagos que se han desprendido
        desde el
        tapizamiento sinusal (catarro sinusal).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l7 level1 lfo14"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Granulomas</u>: pueden
        ser de distintos
        tipos:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7
        level2 lfo14"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Histiocitarios
(linfadenitis
        de Piringer, en la toxoplasmosis).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7
        level2 lfo14"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Tuberculoides
caseificados
        (TBC)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l7
        level2 lfo14"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Tuberculoides
no
        caseificados (sarcoidosis)</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l7
        level2 lfo14"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Supurados
(enfermedad
        por arañazo de gato)</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal" style="text-align:center;tab-stops:145.3pt
        center 261.5pt" align="center"><b
          style="mso-bidi-font-weight:normal"><u><span
              style="font-size:16.0pt;
              mso-bidi-font-size:12.0pt">TEMA 23<o:p></o:p></span></u></b></p>
      <p class="MsoListParagraph"
        style="text-indent:-18.0pt;mso-list:l18 level1 lfo15"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">1.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">HISTIOCITOSIS
            DE CÉLULAS DE
            LANGERHANS<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Proliferación
reactiva
        de células de Langerhans en la medula ósea, provocando distintas
        enfermedades:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><b
          style="mso-bidi-font-weight:normal">Granuloma
          eosinófilo</b>: lesiones nodulares reactivas en hueso (al que
        destruyen) y a
        veces también en partes bandas. Están formadas por una población
        heterogénea de
        eosinófilos, células de Langerhans, linfocitos, células
        plasmáticas y
        fibroblastos.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l23
        level2 lfo12"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Las
células
        de Langerhans son células del sistema fagocítico mononuclear de
        la piel,
        por tanto son mononucleadas; son grandes y de citoplasma claro y
        vacuolado.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l23
        level3 lfo12"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Al
ME
        poseen en su citoplasma <i style="mso-bidi-font-style:normal">gránulos
          de
          Birbeck</i>, con forma de raqueta de tenis con el mango
        membranoso y extremo
        dilatado.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l23
        level2 lfo12"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->La
afectación
        ósea produce múltiples lesiones osteolíticas, dando lugar a
        fracturas.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><b
          style="mso-bidi-font-weight:normal">Enfermedad
          de Hand-Schuller-Christian</b>: se llama así al cuadro cuando
        el granuloma
        eosinófilo es múltiple, y se acompaña de:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l23
        level2 lfo12"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Lesiones
osteolíticas
        en diploe</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l23
        level2 lfo12"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Exoftalmos
(afectación
        retroocular)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l23
        level2 lfo12"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Diabetes
insípida
        (por afectación de la parte posterior del tallo hipofisario)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l23 level1 lfo12"><!--[if !supportLists]--><span
style="mso-ascii-font-family:Cambria;mso-fareast-font-family:Cambria;
          mso-hansi-font-family:Cambria;mso-bidi-font-family:Cambria"><span
            style="mso-list:Ignore">-<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><b
          style="mso-bidi-font-weight:normal">Enfermedad
          de Letterer-Siwe</b>: histiocitosis de células de Langerhans
        aguda y diseminada
        (afecta a piel, huesos, hígado, bazo y pulmones).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l23
        level2 lfo12"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Aparece
en
        niños menores de dos años.</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l23
        level2 lfo12"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Es
muy
        agresiva y requiere quimioterapia.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal" style="text-align:center;tab-stops:145.3pt
        center 261.5pt" align="center"><b
          style="mso-bidi-font-weight:normal"><u><span
              style="font-size:16.0pt;
              mso-bidi-font-size:12.0pt">TEMA 24<o:p></o:p></span></u></b></p>
      <p class="MsoListParagraph"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l4 level1 lfo16"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">1.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">TUMORES
            DE TESTÍCULO<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Los
        tumores de testículo pueden ser principalmente de dos tipos:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l22 level1 lfo17"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Tumores de células
          germinales</u>: son los
        mas frecuentes (&gt;95%), derivan de la NITGI (neoplasia
        intratubular germinal indiferenciada)
        hacia seminoma, carcinoma embrionario, coriocarcinoma, teratoma</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l22 level1 lfo17"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Tumores no germinales
          (del estroma gonadal)</u>:
        tumores de células de Sertoli y Leydig.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">**
        De esta pregunta, al no saber exactamente que poner, yo pondría
        un miniresumen de
        todos los apartados que vienen después: pondría la clasificación
        y el origen de
        los tumores germinales, el estadiaje y los marcadores, y luego
        explicaría un
        poco el seminoma y algo breve de los demás.</p>
      <p class="MsoNormal" style="text-align:center;tab-stops:145.3pt
        center 261.5pt" align="center"><b
          style="mso-bidi-font-weight:normal"><u><span
              style="font-size:16.0pt;
              mso-bidi-font-size:12.0pt"><o:p><span
                  style="text-decoration:none">&nbsp;</span></o:p></span></u></b></p>
      <p class="MsoListParagraph" style="text-indent:-18.0pt;mso-list:l4
        level1 lfo16"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">2.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">TUMORES
            GERMINALES:
            CLASIFICACIÓN, MORFOLOGÍA, DIFERENCIAS<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Los
        tumores de células germinales son los más frecuentes (&gt;95%).
      </p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l21 level1 lfo18"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><u>CLASIFICACIÓN:<o:p></o:p></u></b></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l21
        level2 lfo18"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Seminomas
(y
        sus variantes)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l21
        level2 lfo18"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->No
        seminomas:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l21
        level3 lfo18"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Carcinoma
        embrionario</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l21
        level3 lfo18"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Tumor
del
        seno endodérmico (del saco vitelino)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l21
        level3 lfo18"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Coriocarcinoma</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l21
        level3 lfo18"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Teratoma:
maduro,
        inmaduro, teratocarcinoma.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l21 level1 lfo18"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>MORFOLOGÍA:<o:p></o:p></u></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l21
        level2 lfo18"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Al
proceder
        todos ellos de la NITGI, que luego evoluciona para dar los
        distintos
        tumores, podemos encontrar mezclas de tejidos diferentes,
        incluso que un tejido
        evolucione a otro. El grado de malignidad es inverso al de
        desarrollo embriológico
        (a menos diferenciado, más maligno).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l21
        level2 lfo18"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Muchos
tumores
        pueden ser capaces de producir altos niveles de <span
          style="mso-ascii-font-family:
          Cambria;mso-hansi-font-family:Cambria">&#946;-HCG (si diferencian
          hacia
          trofoblasto) o &#945;-fetoproteína (si diferencian a seno
          endodérmico). Esto es
          útil tanto para el diagnostico inicial, como tras la
          intervención quirúrgica
          (la negativización indica buena intervención) y para detectar
          recaídas (si hay
          reaumento de valores).</span></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l21 level1 lfo18"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>ESTADIAJE CLÍNICO Y
          DIFERENCIAS:<o:p></o:p></u></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l21
        level2 lfo18"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Tras
el
        diagnostico, los tumores deben estadiarse con fines terapéuticos
        y pronósticos,
        pudiendo hacerse según:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l21
        level3 lfo18"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Si
el
        tumor es un seminoma o una neoplasia germinal no seminoma.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:108.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l21
        level3 lfo18"><!--[if !supportLists]--><span
          style="font-family:Wingdings;
mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings"><span
            style="mso-list:Ignore">§<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp; </span></span></span><!--[endif]-->Según
el
        grado tumoral:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l21
        level4 lfo18"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->I: sólo afecta al
        testículo y anejos
        testiculares.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l21
        level4 lfo18"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->II: afecta al testículo
        con metástasis en
        ganglios subdiafragmáticos.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:144.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l21
        level4 lfo18"><!--[if !supportLists]--><span
          style="font-family:Symbol;
          mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol"><span
            style="mso-list:Ignore">·<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->III: metástasis por
        encima y debajo del
        diafragma.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l21
        level2 lfo18"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Gracias
a
        esto obtenemos dos patrones de comportamiento:</p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <table class="MsoTableGrid"
        style="border-collapse:collapse;border:none;mso-border-alt:solid
        windowtext .5pt; mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt
        0cm 5.4pt" cellspacing="0" cellpadding="0" border="1">
        <tbody>
          <tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes">
            <td style="width:265.0pt;border:solid windowtext 1.0pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="265" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center"><b style="mso-bidi-font-weight:normal">TUMORES
                  SEMINOMATOSOS<o:p></o:p></b></p>
            </td>
            <td style="width:265.0pt;border:solid windowtext 1.0pt;
              border-left:none;mso-border-left-alt:solid windowtext
              .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm
              5.4pt 0cm 5.4pt" width="265" valign="top">
              <p class="MsoNormal" style="text-align:center"
                align="center"><b style="mso-bidi-font-weight:normal">TUMORES
                  NO SEMINOMATOSOS<o:p></o:p></b></p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:1">
            <td style="width:265.0pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="265" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Localizados

                en testículo</p>
            </td>
            <td style="width:265.0pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="265" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Sobrepasan

                limites testiculares</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:2">
            <td style="width:265.0pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="265" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">No

                infiltran (no rompen albugínea)</p>
            </td>
            <td style="width:265.0pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="265" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Infiltran

                (albugínea, epidídimo y deferente)</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:3">
            <td style="width:265.0pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="265" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Estadios

                I o II</p>
            </td>
            <td style="width:265.0pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="265" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Estadio

                III</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:4">
            <td style="width:265.0pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="265" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Diseminación

                linfática +</p>
            </td>
            <td style="width:265.0pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="265" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Diseminación

                hematógena +</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:5">
            <td style="width:265.0pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="265" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Respuesta

                a radioterapia</p>
            </td>
            <td style="width:265.0pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="265" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Respuesta

                a quimioterapia</p>
            </td>
          </tr>
          <tr style="mso-yfti-irow:6;mso-yfti-lastrow:yes">
            <td style="width:265.0pt;border:solid windowtext 1.0pt;
              border-top:none;mso-border-top-alt:solid windowtext
              .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm
              5.4pt 0cm 5.4pt" width="265" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Pronóstico

                excelente</p>
            </td>
            <td style="width:265.0pt;border-top:none;border-left:
              none;border-bottom:solid windowtext
              1.0pt;border-right:solid windowtext 1.0pt;
              mso-border-top-alt:solid windowtext
              .5pt;mso-border-left-alt:solid windowtext .5pt;
              mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm
              5.4pt" width="265" valign="top">
              <p class="MsoNormal"
                style="text-align:justify;text-justify:inter-ideograph">Pronóstico

                sombrío</p>
            </td>
          </tr>
        </tbody>
      </table>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l4 level1 lfo16"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">3.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">EVOLUCIÓN
            DE LA NEOPLASIA
            INTRATUBULAR GERMINAL<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">La
        neoplasia intratubular germinal indiferenciada (NITGI) es la
        célula de la cual
        se originan todos los tumores germinales de testículo, según el
        modelo
        tridimensional que sustituye al modelo clásico.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">En este
        modelo, la NITGI puede evolucionar:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l0 level1 lfo19"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Bien intratubular (IT),
        hacia trofoblasto,
        carcinoma embrionario, tumor del seno endodérmico o seminoma</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l0 level1 lfo19"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Bien una vez que ha
        invadido, y se ha
        transformado en un seminoma, hacia el resto de tumores.</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l0 level1 lfo19"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Además, en esta
        diferenciación se separan las
        formas infantiles (teratoma infantil, TSE infantil).</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Esto
        provoca:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l3 level1 lfo20"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Que encontremos mezclas
        de tejidos diferentes en
        los tumores.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l5 level1 lfo21"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Que tumores
        diagnosticados como una variante,
        evolucionen o tengan recurrencias como otro tumor distinto al
        original (por
        ejemplo, de seminoma a tumor del seno endodérmico).</p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l5 level1 lfo21"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Que podamos ver altos
        niveles tanto de <span
          style="mso-ascii-font-family:Cambria;mso-hansi-font-family:Cambria">&#946;-HCG
o
          &#945;-fetoproteína en un mismo tumor.</span></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">El
        grado de potencial maligno es inverso al grado de
        diferenciación: cuanto más
        primitivo e indiferenciado, más maligno es un tumor.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l4 level1 lfo16"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">4.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">SEMINOMA<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Es
        el tumor germinal más frecuente (50% de los casos), típico de
        adultos de 30-40
        años.</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Hay
        variantes, pero el seminoma clásico es:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l8 level1 lfo22"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Macro</u>: masa
        localizada en el testículo,
        que no infiltra (no rompe la albugínea), con pocas áreas de
        necrosis. Color
        blanquecino.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l8 level1 lfo22"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Micro</u>: células
        homogéneas, dispuestas en
        lóbulos, con citoplasma PAS+ y núcleos redondos. Entre ellos,
        infiltrado de
        linfocitos T característico.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l8 level1 lfo22"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Hormonas</u>:
        normalmente no producen, en un
        10-15% <span
          style="mso-ascii-font-family:Cambria;mso-hansi-font-family:Cambria">&#946;-HCG,
pero
          NUNCA &#945;-fetoproteína.</span></p>
      <p class="MsoListParagraphCxSpLast"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l8 level1 lfo22"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u><span
            style="mso-ascii-font-family:Cambria;
            mso-hansi-font-family:Cambria">Pronóstico</span></u><span
          style="mso-ascii-font-family:
          Cambria;mso-hansi-font-family:Cambria">: la mayoría se
          encuentran en estadio I
          (localizados), siendo su pronostico excelente. Cuando da
          metástasis, son
          linfáticas, y responde bien a la radioterapia.</span></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">**
        De todos los tumores no seminomas, llegado el caso, podéis poner
        de todos ellos
        lo que aparece en la tabla: estadio III, muy infiltrativos,
        metástasis a
        distancia, pobre pronostico, tratamiento con quimioterapia Muy
        resumidos, son:</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l14 level1 lfo23"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]-->Carcinoma embrionario:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l14
        level2 lfo23"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Más
precoz
        y agresivo que el seminoma, con frecuente infiltración
        (albugínea,
        epidídimo y cordón) y frecuentes áreas de necrosis y hemorragia.
        Muy
        indiferenciados.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l14
        level2 lfo23"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Secreción
de
        <span
          style="mso-ascii-font-family:Cambria;mso-hansi-font-family:Cambria">&#946;-HCG
o
          &#945;-fetoproteína según su diferenciación (incluso ambos en
          mixtos).</span></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l14 level1 lfo23"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><span
          style="mso-ascii-font-family:Cambria;
          mso-hansi-font-family:Cambria">Tumor del saco vitelino:</span></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l14
        level2 lfo23"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><span
style="mso-ascii-font-family:Cambria;mso-hansi-font-family:Cambria">Rara
          neoplasia, típica de niños pequeños. Muy raro en forma pura.</span></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l14
        level2 lfo23"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><span
style="mso-ascii-font-family:Cambria;mso-hansi-font-family:Cambria">Formada
          por
          células cubicas dispuestas en estructuras glomerulares,
          llamados cuerpos de
          Schiller-Duval, que poseen &#945;-fetoproteína, que es PAS+.</span></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l14 level1 lfo23"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><span
          style="mso-ascii-font-family:Cambria;
          mso-hansi-font-family:Cambria">Coriocarcinoma:</span></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l14
        level2 lfo23"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><span
style="mso-ascii-font-family:Cambria;mso-hansi-font-family:Cambria">Muy
          raro
          también en forma pura, casi siempre son transformaciones de
          otros tumores.</span></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l14
        level2 lfo23"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><span
style="mso-ascii-font-family:Cambria;mso-hansi-font-family:Cambria">Produce
          &#946;-HCG.</span></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l14 level1 lfo23"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><span
          style="mso-ascii-font-family:Cambria;
          mso-hansi-font-family:Cambria">Teratoma: </span></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l14
        level2 lfo23"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><span
style="mso-ascii-font-family:Cambria;mso-hansi-font-family:Cambria">Diferencian
hacia
          estructuras embrionarias de las tres hojas.</span></p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l14
        level2 lfo23"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]--><span
style="mso-ascii-font-family:Cambria;mso-hansi-font-family:Cambria">Puede
          ser
          maduro (elementos maduros de las hojas), inmaduro o
          teratocarcinoma
          (transformación maligna).</span></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoListParagraph"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l4 level1 lfo16"><!--[if !supportLists]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:
12.0pt;mso-fareast-font-family:Cambria;mso-fareast-theme-font:minor-latin;
mso-bidi-font-family:Cambria;mso-bidi-theme-font:minor-latin"><span
              style="mso-list:Ignore">5.<span style="font:7.0pt
                &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;
              </span></span></span></b><!--[endif]--><b
          style="mso-bidi-font-weight:normal"><span
            style="font-size:14.0pt;mso-bidi-font-size:12.0pt">CARCINOMA
            DE PRÓSTATA<o:p></o:p></span></b></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph">Neoplasia
maligna
        más frecuente en el hombre (incluso mas que pulmón), aunque no
        es el de
        más alta mortalidad (debido a la alta incidencia de
        descubrimiento accidental o
        postmortem).</p>
      <p class="MsoListParagraphCxSpFirst"
        style="text-align:justify;text-justify:inter-ideograph;
        text-indent:-18.0pt;mso-list:l2 level1 lfo24"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Factores
          predisponentes:<o:p></o:p></u></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Raciales:
mas
        frecuente en raza negra, y menor en asiáticos.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Ambientales:
incremento
        tras emigración a país de raza blanca.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Dietéticos:
incremento
        si consumo excesivo de grasas.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Hormonales:
relación
        directa (ya que no hay carcinoma en orquiectomizados).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Genéticos:
importante
        gen de susceptibilidad del cromosoma 1 (alta incidencia cáncer).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l2 level1 lfo24"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Macro:<o:p></o:p></u></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Localización
periférica.
        Consistencia aumentada a la palpación.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Hay
uno
        o varios nódulos que contrastan con el tejido normal (aunque a
        veces están entremezclados
        y es difícil separarlos).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l2 level1 lfo24"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Micro: <o:p></o:p></u></p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->5
        grados de diferenciación según patrón histológico, de 1 (bien
        diferenciado, con
        glándulas pequeñas y similares entre si, estroma interpuesto) a
        5 (mal
        diferenciado, sin disposición glandular). </p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Signos
de
        malignidad: infiltración perineural, ausencia de células
        mioepiteliales en
        la periferia de las glándulas tumorales (que si están en
        glándulas normales). </p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Inmunohistoquímica:
útil
        para diferenciar en tumores de alto grado.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l2 level1 lfo24"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Diseminación</u>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Por
continuidad
        (vesículas, vejiga)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Vía
linfática
        (ganglios obturadores, iliacos, hipogástricos)</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Vía
hematógena
        (metástasis óseas, principalmente osteoblásticas).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l2 level1 lfo24"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Diagnóstico</u>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Tacto
rectal
        y ecografía transrrectal, con biopsia de áreas sospechosas.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->PSA:
útil
        si &gt;9/10ng/ml, pero no especifico (puede deberse a otras
        causas
        prostáticas).</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l2 level1 lfo24"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Pronóstico</u>:</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Clasificación
de
        Gleason: es la suma de la puntuación de los dos patrones
        predominantes de
        diferenciación del tumor (de 1, bien diferenciado, a 5, muy
        indiferenciado);
        sirve para clasificarlo según la diferenciación tumoral, y
        servir como
        indicador pronostico.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="margin-left:72.0pt;mso-add-space:
        auto;text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;
mso-list:l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Depende
de
        la edad: más agresivas en &lt;60 años, menos en &gt;80 años.
        Importante el
        diagnostico precoz.</p>
      <p class="MsoListParagraphCxSpMiddle"
        style="text-align:justify;text-justify:
        inter-ideograph;text-indent:-18.0pt;mso-list:l2 level1 lfo24"><!--[if !supportLists]--><span
style="font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
          Symbol"><span style="mso-list:Ignore">·<span style="font:7.0pt
              &quot;Times New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
            </span></span></span><!--[endif]--><u>Tratamiento</u>: </p>
      <p class="MsoListParagraphCxSpLast"
        style="margin-left:72.0pt;mso-add-space:auto;
        text-align:justify;text-justify:inter-ideograph;text-indent:-18.0pt;mso-list:
l2
        level2 lfo24"><!--[if !supportLists]--><span
          style="font-family:&quot;Courier New&quot;;
          mso-fareast-font-family:&quot;Courier New&quot;"><span
            style="mso-list:Ignore">o<span style="font:7.0pt &quot;Times
              New Roman&quot;">&nbsp;&nbsp; </span></span></span><!--[endif]-->Cirugía,
radioterapia
        y hormonoterapia androgénica (para casos avanzados).</p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
      <p class="MsoNormal"
        style="text-align:justify;text-justify:inter-ideograph"><o:p>&nbsp;</o:p></p>
    </div>
  </body>
</html>
